Effects of ADAM17-shRNA on proliferation of human breast cancer MCF-7 cells

Xiangchao MENG,Zhun CAI,Guofu CHEN,Lijun WU,Xuepeng ZHANG
DOI: https://doi.org/10.3969/j.issn.1002-266X.2017.04.004
2017-01-01
Abstract:Objective To investigate the effect of a disintegrin and metalloprotease 17 ( ADAM17 )-shRNA on the proliferation of human breast cancer MCF-7 cells and to explore its possible mechanism .Methods MCF-7 cells were di-vided into the nonsense group , control group ( PBS) and transfection group .Four specific ADAM17-shRNAs ( ADAM17-shRNA-1219, ADAM17-shRNA-1508, ADAM17-shRNA-1134 and ADAM17-shRNA-297) were designed and synthesized for ADAM17 gene.MCF-7 cells were transfected by electroporation .The nonsense group was transfected by ADAM 17-shNC, the control group was added with PBS , and the transfection group was transfected by ADAM 17-shRNA-1219, AD-AM17-shRNA-1508, ADAM17-shRNA-1134 and ADAM17-shRNA-297, respectively.The expression of ADAM17 mRNA, the expression of ADAM17 protein, cell growth curve, proliferation activity and cell cycle of MCF-7 cells was respectively detected by real-time PCR, Western blotting, iCELLigence and flow cytometry .Results Four ADAM17-shRNA se-quences inhibited the expression of ADAM 17 gene, the shRNA1219 vector had the highest inhibitory efficiency , and com-pared with the nonsense group and control group , there was significant difference (all P<0.05).The expression level of ADAM17 mRNA and protein in the transfection group was significantly lower than that in the nonsense group and control group (all P<0.05).The cell proliferation activity and cell growth rate of the transfection group were significantly lower than those of the nonsense group and the control group (all P<0.05).The percentage of cells in S phase and G 2/M phase decreased in the transfection group , and most of the cells stayed in G0/G1 phase, which were significantly different from those in the control group and nonsense group (all P<0.05).Conclusion ADAM17-shRNA can inhibit the proliferation of human breast cancer MCF-7 cells, and the mechanism is related to its silencing effect on ADAM 17 gene.
What problem does this paper attempt to address?